With Case Studies and Lessons Learned from Industry Experts!

* Optimizing Formulation and Product Development in Early Clinical Research

- Presentation by Jason Vaughn, Patheon

* Nanosuspension Formulation and Process Optimization for Improved Bioavailability of Poorly Soluble Drug Compounds

            - Presented by Indrajit Ghosh, Celgene

* Successful Formulation Strategies for Amorphous Solid Dispersions

             - Presented by Duk Soon Choi, Roche

* Role of Small Molecule Colloid Formation on Oral Absorption

            - Presented by Liping Zhou, Novartis

*  Effects of Manufacturing Process on Solid Dispersion Stability and Bio-Performance

            - Presented by Michael Lowinger, Merck

* Adapting QbD Principles to Solubilization Formulation Development

- Presented by Marshall Crew, Agere Pharmaceuticals

And Many More! Including Special Coverage On:

* Intellectual Property Considerations for Solid Form Drug Compounds

* Supersaturation & Precipitation Behavior of Poorly Soluble Drugs

* Rational Formulation Design for Poorly Soluble Drugs

* Co-Crystallization Techniques to Optimize Solubility

* Innovations in Discovery Pharmaceutics for Poorly Soluble Compounds

* Recent Developments in Lipid-Based Drug Delivery

* Considerations for Toxicology Formulations of Poorly Soluble Compounds

Featuring Representation From:

Novartis        Merck                        Celgene          Roche                         Cubist

Patheon         Aptuit             Takeda           Capsugel                    Agere

Quotient        Agios              Pion                Sirius Analytical

Center for Pharmaceutical Physics         H. Lundbeck